Pain Management in Prostate Cancer Patients in Africa

Abstract Prostate cancer is the second most common malignancy and the leading cause of cancer death in men across Sub-Saharan Africa (SSA). Despite lower reported incidence rates compared to African American men, actual prostate cancer prevalence in SSA is under-reported and likely underestimated due to inadequate screening and limited access to healthcare. This study analyzed registry data from 13,170 prostate cancer cases across 11 SSA countries to evaluate trends in incidence rates over time. Findings revealed a significant increase in cumulative risks (CR) and age-standardized incidence rates (ASR) over time. Despite this increasing incidence, opioid consumption for pain management in cancer care remains low and stagnant across the continent, reflecting an important gap in palliative care services. As cancer incidence in SSA is projected to rise dramatically by 2050, there is an urgent need for policy interventions to improve access to diagnostic services, cancer care, and adequate pain management.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-11-21
DOI
https://doi.org/10.5281/zenodo.17845993
Primary Topic
Pain Management and Opioid Use
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pain Management in Prostate Cancer Patients in Africa

Zenodo (CERN European Organization for Nuclear Research)
Pain Management and Opioid Use
article

Pain Management in Prostate Cancer Patients in Africa

article en

Abstract

Abstract Prostate cancer is the second most common malignancy and the leading cause of cancer death in men across Sub-Saharan Africa (SSA). Despite lower reported incidence rates compared to African American men, actual prostate cancer prevalence in SSA is under-reported and likely underestimated due to inadequate screening and limited access to healthcare. This study analyzed registry data from 13,170 prostate cancer cases across 11 SSA countries to evaluate trends in incidence rates over time. Findings revealed a significant increase in cumulative risks (CR) and age-standardized incidence rates (ASR) over time. Despite this increasing incidence, opioid consumption for pain management in cancer care remains low and stagnant across the continent, reflecting an important gap in palliative care services. As cancer incidence in SSA is projected to rise dramatically by 2050, there is an urgent need for policy interventions to improve access to diagnostic services, cancer care, and adequate pain management.

Zenodo (CERN European Organization for Nuclear Research)
Howard University (US), University of Massachusetts Amherst (US), Loma Linda University (US)
Good health and well-being
Openalex Percentile: Top 29%
Pain Management and Opioid Use
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.